Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Vilaseca A, Ribal MJ. Eur Urol 2022 Jul 27. pii: S0302-2838(22)02526.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vilaseca A, Ribal MJ. Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Eur Urol 2022 Jul 27. pii: S0302-2838(22)02526.
PMID: 35907664